biotech investing Standard BioTools Announces Sale of Mass Cytometry Business and Illumina's Buyout of Contingent Payments to Advance Merger with Treeline Biosciences
biotech investing Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026
biotech investing Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction
biotech investing Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
biotech investing Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
Brixton Metals Announces Closing of Option Agreement to Acquire a 100% Interest in the Silver Focused Silvergruvan Project in Sweden
Spartan Metals Expands Victorio Tungsten-Molybdenum Resource with Measured and Indicated Grades of 0.25% MoEq or 0.15% WO3Eq
